Hologic Stock Last Dividend Paid
HO1 Stock | EUR 68.00 1.00 1.45% |
Hologic fundamentals help investors to digest information that contributes to Hologic's financial success or failures. It also enables traders to predict the movement of Hologic Stock. The fundamental analysis module provides a way to measure Hologic's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Hologic stock.
Hologic |
Hologic Company Last Dividend Paid Analysis
Hologic's Last Dividend Paid refers to dividend per share(DPS) paid to the shareholder the last time dividends were issued by a company. In its conventional sense, dividends refer to the distribution of some of a company's net earnings or capital gains decided by the board of directors.
More About Last Dividend Paid | All Equity Analysis
Last Dividend | = | Last Profit Distribution AmountTotal Shares |
Many stable companies today pay out dividends to their shareholders in the form of the income distribution, but high-growth firms rarely offer dividends because all of their earnings are reinvested back to the business.
Competition |
Based on the recorded statements, Hologic has a Last Dividend Paid of 0.0. This indicator is about the same for the Healthcare average (which is currently at 0.0) sector and about the same as Medical Instruments & Supplies (which currently averages 0.0) industry. This indicator is about the same for all Germany stocks average (which is currently at 0.0).
Hologic Last Dividend Paid Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Hologic's direct or indirect competition against its Last Dividend Paid to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Hologic could also be used in its relative valuation, which is a method of valuing Hologic by comparing valuation metrics of similar companies.Hologic is currently under evaluation in last dividend paid category among its peers.
Hologic Fundamentals
Return On Equity | 0.21 | |||
Return On Asset | 0.0858 | |||
Profit Margin | 0.22 % | |||
Operating Margin | 0.29 % | |||
Current Valuation | 18.25 B | |||
Shares Outstanding | 246.55 M | |||
Shares Owned By Insiders | 0.73 % | |||
Shares Owned By Institutions | 99.99 % | |||
Price To Book | 3.70 X | |||
Price To Sales | 3.52 X | |||
Revenue | 4.86 B | |||
Gross Profit | 3.31 B | |||
EBITDA | 2.11 B | |||
Net Income | 1.3 B | |||
Cash And Equivalents | 601.8 M | |||
Cash Per Share | 2.24 X | |||
Total Debt | 2.81 B | |||
Debt To Equity | 134.00 % | |||
Current Ratio | 1.67 X | |||
Book Value Per Share | 20.66 X | |||
Cash Flow From Operations | 2.13 B | |||
Earnings Per Share | 3.64 X | |||
Price To Earnings To Growth | 0.91 X | |||
Target Price | 85.5 | |||
Number Of Employees | 6.94 K | |||
Beta | 1.03 | |||
Market Capitalization | 18.19 B | |||
Total Asset | 9.07 B | |||
Z Score | 3.6 | |||
Net Asset | 9.07 B |
About Hologic Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Hologic's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Hologic using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Hologic based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Hologic Stock
When determining whether Hologic offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Hologic's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Hologic Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Hologic Stock:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hologic. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For more detail on how to invest in Hologic Stock please use our How to Invest in Hologic guide.You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.